Cross-posted from my Substack.
Epistemic status: I’ve puzzled over this for a long time but I’m not sure I came to the right answers. I'm sharing this partly because it might help others work on resource allocation, but mostly because some smarter reader might tell me how to do it better.
TL;DR:
* I he...
With the AI windfall, mental health may be taken increasingly seriously by mainstream EA. There’s increasingly room to explore the cause area and answer some of the biggest uncertainties; at the same time, costs of the most effective interventions are continuing to fall. StrongMinds is now treating for ~$35, about a third of GiveWell’s best guess from a few years ago, and is expected to...
[Related to: Logarithmic Scales of Pleasure and Pain; Anti-Tolerance Drugs]
Millions of people suffering from benzo/gabapentin/phenibut/alcohol withdrawal across the world thinking that tapering is the only solution, while it seems like people in Italy and Japan already figured out how to reverse tolerance without side-effects within a week? It's called Flumazenil and it's a GABAa antagonist, which when taken in microdoses can up-regulate GABA receptors (hear me out: up-regulation and other tolerance mechanisms are *not* proportional to subjective effect size - this insight makes all the difference).
See the wikipedia entry on it:
See also a video I made about why our common-sense view of how drug tolerance works gets in the way of actually solving this crisis.